be possible to explain the difference of the two recovery courses solely on the concept of a "margin of safety" in enzyme inhibition. Further study will be necessary to reveal the mechanism of the accelerated reversal by divided administration of anticholinesterase.
In conclusion, from a clinical view, it is recommended to administer neostigmine in a 0.4 mg dose every three minutes until an adequate recovery of neuromuscular function is achieved. If anesthesiologists administer neostigmine in a one-bolus-injection, they have to take into consideration that the speed of recovery from blockade is slow when the TOF ratio is above 50%. 
CORRECTION
.In the article entitled "Effects of Anesthetic and Related Agents on Calciuminduced Calcium Release from Sarcoplasmic Reticulum Isolated from Rabbit Skeletal Muscle" (J Anesth 3: 1-9, 1989), there are errors in the units of measurement. On page 5, legend of table 1, third sentence should have read ".. ·138 n mol Ca2+ /mg protein/min...," not ".. ·138 JLM Ca2+ /min·· .," as printed. On page 6, first sentence in the legend for table 2 should have also read ".. ·SR (n mol Ca2+ /1.5 mg protein)," not ".. ·SR (JLM Ca2+ /mg SR protein)."
